20
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Possible Impairment by Venlafaxine: A Case Report

, &
Pages 31-33 | Published online: 22 Nov 2013

REFERENCES

  • Compendium of Pharmaceuticals and Specialties, 31 st edition, Canadian Pharmaceutical Association, Ottawa, 1996.
  • Troy S.M., Parker V.D., Fruncillo R.J. and Chiang S.T. The Pharmacokinetics of Venlafaxine when Given in a Twice-Daily Regimen. J. Clin. Pharmacol. 1995; 35: 404–409.
  • Holliday S.M. and Benfied P. Venlafaxine—A Review. Drugs 1995; 49: 280–294.
  • Danjou P. and Hackett D. Safety and Tolerance Profile of Venlafaxine. International Clinical Psychopharmacology 1995; 10 Suppl. 2: 15–20.
  • Levine B., Jenkins A.J., Queen M., Jufer R. and Smialek J.E. Distribution of Venlafaxine in Three Postmortem Cases. J. Anal. Tox. 1996; 20: 502–505.
  • Parsons A.T., Anthony R.M. and Meeker J.E. Two Fatal Cases of Venlafaxine Poisoning. J. Anal. Tox. 1996; 20: 266–268.
  • Sharp M.E. A Rapid Screening Procedure for Acidic and Neutral Drugs in Blood by High Resolution Gas Chromatography. J. Anal. Tox. 1987; 11: 8–30.
  • Sharp M.E. Evaluation of a Screening Procedure for Basic and Neutral Drugs: n-Butyl Chloride Extraction and Megabore Capillary Gas Chromatography. Can. Soc. Forens. Sci. J. 1986; 19: 83–101.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.